Belfast · Northern Ireland
TheBELFAST HERALDLocal knowledge. National perspective.
Retrospective archiveHistorical reports were compiled from linked contemporaneous sources. Dates refer to the events covered.How the archive works
HealthPremium archive

Swissmedic approves the extension of booster doses of the Pfizer–BioNTech COVID-19 vaccine to people over the age of 16 years as well as high-risk people

Swissmedic approves the extension of booster doses of the Pfizer–BioNTech COVID-19 vaccine to people over the age of 16 years as well as high-risk people over the age of 12 years.

By Belfast Herald Newsdesk1 min read

Herald Premium Archive

This report is for subscribers

Sign in or choose a plan to read this report and the complete Premium retrospective archive.

HealthSwissmedic approves the extension of booster doses of the Pfizer–BioNTech COVID-19 vaccine to people over the age of 16 years as well as high-risk people

Swissmedic approves the extension of booster doses of the Pfizer–BioNTech COVID-19 vaccine to people over the age of 16 years as well as high-risk people over the age of 12 years.

View Premium plansBrowse free archive reports